A noninterventional study to monitor patients with diabetic macular oedema starting treatment with ranibizumab (POLARIS)-Reference-Cited by-同舟云学术

A noninterventional study to monitor patients with diabetic macular oedema starting treatment with ranibizumab (POLARIS)

Published:2018-04-25 Issue:8 Volume:96 Page:e942-e949
ISSN:1755-375X
Container-title:Acta Ophthalmologica
language:en
Short-container-title:Acta Ophthalmol

Author:

Stefanickova Jana¹,Cunha-Vaz Jose²,Ulbig Michael³,Pearce Ian⁴,Fernández-Vega Sanz Alvaro⁵,Theodossiadis Panagiotis⁶,Kodjikian Laurent⁷,Izmailov Alexander⁸,Muston Dominic⁹,Vassilev Zdravko⁹,Lamotte Benedicte⁹,Tückmantel Claudia¹⁰,Friedl Sabine¹¹,Altemark Andreas¹¹,Schwarz Hans-Jörg¹²,Katz Todd⁹,

Affiliation:

1. Department of Ophthalmology; Medical Faculty; Comenius University; Bratislava Slovakia

2. Association for Innovation and Biomedical Research on Light and Image (AIBILI, Portugal); University of Coimbra; Coimbra Portugal

3. Department of Ophthalmology; Technical University of Munich; Munich Germany

4. St. Paul's Eye Unit; Royal Liverpool University Hospital; Liverpool UK

5. Fernández-Vega Ophthalmology Institute; Oviedo Spain

6. Attikon University General Hospital; 2nd University Ophthalmology Clinic; University of Athens; Athens Greece

7. Department of Ophthalmology; Croix-Rousse Teaching Hospital; University of Medicine Lyon 1; Lyon France

8. FSBI The Academician S.N. Fyodorov IRTC ‘Eye Microsurgery’ of the Minzdravsocrazvitiya - St. Petersburg; Saint Petersburg Russia

9. Bayer US; LLC; Whippany NJ USA

10. Bayer AG; Wuppertal Germany

11. Bayer AG; Berlin Germany

12. Kantar Health GmbH; Munich Germany

Funder

Bayer

Publisher

Wiley

Subject

Ophthalmology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/aos.13771/fullpdf

Reference30 articles.

1. Outcomes with as-needed ranibizumab after initial monthly therapy: long-term outcomes of the phase III RIDE and RISE trials;Boyer;Ophthalmology,2015

2. Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE;Brown;Ophthalmology,2013

3. Intravitreal ranibizumab for diabetic macular oedema: 1-year experiences in a clinical setting;Brynskov;Acta Ophthalmol,2013

4. Diabetic retinopathy;Cheung;Lancet,2010

5. Diabetic macular edema diagnosis and treatment in the real world: an analysis of Medicare claims data (2008 to 2010);Dugel;Ophthalmic Surg Lasers Imaging Retina,2016

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KESTREL and KITE Phase 3 Studies: 100-Week Results With Brolucizumab in Patients With Diabetic Macular Edema;American Journal of Ophthalmology;2024-04

2. Volkskrankheit diabetische Retinopathie;Diabetes aktuell;2023-11

3. Management of diabetic macular oedema in France from 2012 to 2018: The nationwide LANDSCAPE study;Acta Ophthalmologica;2023-10-24

4. Volkskrankheit diabetische Retinopathie;Klinische Monatsblätter für Augenheilkunde;2023-09

5. Exploring the role of retinal fluid as a biomarker for the management of diabetic macular oedema;Eye;2023-07-21